CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

New rumors indicate that Tesla will buy equipment from CATL to start production of LFP cells in Sparkes, Nevada. The EV maker is struggling to ramp up 4680 cell production and also needs to produce ...

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...

A research group led by Professor SUZUKI Hiroaki from Faculty of Science and Engineering at Chuo University, graduate students YONEYAMA Ryotaro (at the time), MORIKAWA Naoya, and USHIYAMA Ryota (at ...